Medimmune Synagis DTC Ads Revamped To Target Mothers With Babies
Executive Summary
Medimmune is retooling the direct-to-consumer ad campaign for its respiratory syncytial virus therapy Synagis (palivizumab), as the product enters its third RSV season on the market.